StockPulse is a software subscription service that translates and summarizes U.S. stock filings and news into alerts. It is not an investment advisory, brokerage, or discretionary management service.

All information provided (filing summaries, price data, keywords, etc.) is processed from public sources for reference only and is not a recommendation to buy or sell any security. Investment decisions and their outcomes are the sole responsibility of the user.

노마드랩 주식회사 · 대표 황승준 · 사업자등록번호 588-81-01342

부산광역시 해운대구 센텀중앙로 55, 9층 7호(우동)

통신판매업 제2026-부산해운대-0983호 · 문의  

고객문의 070-4268-1176

App Store▶ Google Play
GuideFAQWeeklyTerms of ServicePrivacy PolicyPayment & Refund Policy

StockPulse · 스탁펄스(스톡펄스) — 미국주식 공시·뉴스 실시간 알림

© 2026 노마드랩 주식회사. All rights reserved.

StockPulseStockPulseFeedReportMacro·SectorsCommunityAlertsMy
Theme
FeedReportMacro·SectorsCommunityAlertsMy
CTXRCitius Pharmaceuticals, Inc.
stockpulse.co.kr
Nasdaq
$0.4100▲ 2.30%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $11.3MShares out 27.4M sh
At a glance🔒 At-a-glance is MAX onlySee plans

Chart

Filings & news by date

Hover (PC) or tap (mobile) a candle to see that day only

🔒 Members only
Live tape🔒 Live tape is MAX onlySee plans

Filings

2
  • 8.21After-hours26.08.22 05:15
    8-KKey event#●●●#●●●

    Citius Pharmaceuticals, Inc.

    Citius Pharmaceuticals has been granted an extension by Nasdaq until February 8, 2027, to regain compliance with the $1.00 per share minimum bid price requirement. To satisfy the listing rule, the company's common stock must close at or above $1.00 for at least ten consecutive business days before the deadline.…more

    $0.4100+2.30%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
    View filingShare
  • 8.5Pre-market26.08.05 22:27
    8-KKey event

    Citius Pharmaceuticals, Inc.

    Citius Oncology의 암 치료제 LYMPHIR이 2026년 6월 30일 마감 분기에 신규 주문 기관 수가 전 분기 대비 78% 증가하며 상업적 성장세를 보였다. 현재 LYMPHIR은 42개 기관에 공급되고 있으며, 회사는 연말까지 100개 우선순위 기관에 처방집 등재를 완료하는 것을 목표로 한다.…more

    $0.4100+2.30%vs prev close
    View filingShare

1 more filings

Sign up free to unlock the full feed and real-time filing & news alerts.

  • ✓Free — no card required
  • ✓Full real-time filing & news feed
  • ✓Daily Today Report
Sign up free & see allPreview the Today Report →

News

GlobeNewswire

No news collected yet. New articles will appear here.